| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/01/2005 | WO2005080555A1 Monoclonal antibody specific to cell surface protein of human embroyonic stem cell |
| 09/01/2005 | WO2005080554A1 Method of controlling the differentiation of embryonic stem cells |
| 09/01/2005 | WO2005080550A1 Lactic acid with high nisin-productivity and method of selecting the same |
| 09/01/2005 | WO2005080441A1 Method for improving a polymerisation reaction by taking out and analysing a sample |
| 09/01/2005 | WO2005080436A2 Antibodies that bind pote and uses thereof |
| 09/01/2005 | WO2005080435A1 Monoclonal antibody and use thereof |
| 09/01/2005 | WO2005080434A1 Anti-clusterin oligoclonal antibodies for diagnosis and prediction of the aggressiveness of tumours, diagnostic method and related kits |
| 09/01/2005 | WO2005080430A2 Anti-ube4a/ufd2b polyclonal antibody and its use thereof as diagnostic and prognostic marker of 11q23 region alterations |
| 09/01/2005 | WO2005080415A1 Epstein-barr virus (ebv) peptides and method for diagnosis of ebv-associated disease |
| 09/01/2005 | WO2005080414A1 Peptide mimotopes of mycobacterial mannosylated lipoglycans and uses thereof |
| 09/01/2005 | WO2005080407A1 Derivatised phospholipids |
| 09/01/2005 | WO2005080389A1 Indazole-carboxamide compounds as 5-ht4 receptor agonists |
| 09/01/2005 | WO2005079994A1 Device and method for separation and recovery |
| 09/01/2005 | WO2005079976A1 Method for testing for bioaccumulation |
| 09/01/2005 | WO2005079862A1 USE OF RESISTIN ANTISENSE OLIGONUCLEOTIDES AND/OR siRNA MOLECULES IN THE TREATMENT OF RHEUMATOID ARTHRITIS |
| 09/01/2005 | WO2005079847A1 NUCLEAR TRANSFER PROMOTER FOR Cdc42 PROTEIN AND METHOD OF SCREENING THE SAME |
| 09/01/2005 | WO2005079846A1 NUCLEAR TRANSFER PROMOTER FOR Rac PROTEIN AND METHOD OF SCREENING THE SAME |
| 09/01/2005 | WO2005079837A1 Methods of modulating il-23 activity; related reagents |
| 09/01/2005 | WO2005079834A1 Use of dmbt1 for capturing sulphate and phosphate group exposing agents |
| 09/01/2005 | WO2005079822A2 Pharmaceutical composition comprising a fibrin matrix and dermal fibroblasts for the treatment of wounds |
| 09/01/2005 | WO2005079821A1 Wound healing profile |
| 09/01/2005 | WO2005079810A1 USES OF ERβ MODULATORS |
| 09/01/2005 | WO2005079669A1 Method, apparatus and kit for breath diagnosis |
| 09/01/2005 | WO2005079458A2 ENHANCEMENT OF Th2-DEPENDENT AND INFLAMMATORY RESPONSE |
| 09/01/2005 | WO2005079434A2 Modulation of epidermal growth factor heterodimer activity |
| 09/01/2005 | WO2005079420A2 Chromatographic exclusion agglutination assay and methods of use thereof |
| 09/01/2005 | WO2005079410A2 Biological profiles and methods of use |
| 09/01/2005 | WO2005079325A2 Genetic predictability for acquiring a disease or condition |
| 09/01/2005 | WO2005079316A2 Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha 1h, encoded proteins and methods of use thereof |
| 09/01/2005 | WO2005079280A2 High throughput screening methods for lubricating oil compositions |
| 09/01/2005 | WO2005079279A2 High throughput screening methods for fuel compositions |
| 09/01/2005 | WO2005079278A2 High throughput screening methods for lubricating oil compositions |
| 09/01/2005 | WO2005079277A2 High throughput screening methods for lubricating oil compositions |
| 09/01/2005 | WO2005079243A2 Compositions and methods for identifying sperm for forensic applications |
| 09/01/2005 | WO2005079135A2 Method and device for the determination of several analytes with simultaneous internal verification in a graphical combination |
| 09/01/2005 | WO2005066275A3 Sensor devices containing co-polymer substrates for analysis of chemical and biological species in water and air |
| 09/01/2005 | WO2005065102A3 Improved method and apparatus for measuring cell-by-cell hemoglobin |
| 09/01/2005 | WO2005064346A3 Use of anti-parafibromin antibodies to diagnose hyperparathyroidism-jaw tumor syndrome (hpt-jt) and parathyroid cancer |
| 09/01/2005 | WO2005064307A3 Method of assessing rheumatoid arthritis by measuring anti-ccp and interleukin 6 |
| 09/01/2005 | WO2005062865A3 Optically encoded particles with grey scale spectra |
| 09/01/2005 | WO2005054290A3 Peptide hormones zalpha48 and zsig97 |
| 09/01/2005 | WO2005054283A3 Clp-protease as target for herbicides |
| 09/01/2005 | WO2005052566A3 Gas sensor device |
| 09/01/2005 | WO2005051905A3 Large-area two-dimensional non-adhesive cell arrays for sensing and cell-sorting applications |
| 09/01/2005 | WO2005047476A3 Inhibition of retroviral replication through modulation of the host cell ubiquitylation |
| 09/01/2005 | WO2005046859A3 System and method for carrying out multiple binding reactions in an array format |
| 09/01/2005 | WO2005044962A3 High througput preparation of lubricating oil compositions for combinatorial libraries |
| 09/01/2005 | WO2005044838A3 Cd4+ epitopes of bone morphogenetic proteins |
| 09/01/2005 | WO2005043992A9 Attention-deficient hyperactivity disorder (adhd) model mouse |
| 09/01/2005 | WO2005040402A3 Diagnostics and therapeutics for diseases associated with n-acetylated alpha-linked acidic dipeptidase 2 (naaladase 2) |
| 09/01/2005 | WO2005040211A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 1 (gpr1) |
| 09/01/2005 | WO2005035552A3 Transducing combinatorial peptide library |
| 09/01/2005 | WO2005031001A3 Novel therapeutic targets in cancer |
| 09/01/2005 | WO2005029705A3 Number coding for identification of subtypes of coded types of solid phase carriers |
| 09/01/2005 | WO2005024426A3 HIGH-THROUGHPUT-ASSAY WITH HIGH SENSITIVITY FOR MEASURING OF THE ACTIVITY OF β-ADRENERGIC RECEPTOR KINASE AND FOR DETERMINING THE IMPACT OF TEST SUBSTANCES ON SUCH ACTIVITY |
| 09/01/2005 | WO2005017196A3 A method for the identification of irs protein kinase inhibitors or agonists |
| 09/01/2005 | WO2005013950A3 Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases |
| 09/01/2005 | WO2005005981A3 Bio-electrochemical process for producing hydrogen |
| 09/01/2005 | WO2004103394B1 Method and compositions for nerve regeneration |
| 09/01/2005 | WO2004097577A3 Methods, software arrangements, storage media, and systems for providing a shrinkage-based similarity metric |
| 09/01/2005 | WO2004083813A3 Method and apparatus for measuring concentration of a chemical component in a gas mixture |
| 09/01/2005 | WO2004062475A3 Fluorescent assays for protein kinases |
| 09/01/2005 | WO2004044553A3 Lepidoptera voltage-gated calcium channels |
| 09/01/2005 | WO2004042019A3 Systems for capture and analysis of biological particles and methods using the systems |
| 09/01/2005 | WO2004030719A8 Hemostatic puncture closure with depth indicator |
| 09/01/2005 | WO2004024076A8 Novel compositions and methods for the treatment of immune related diseases |
| 09/01/2005 | WO2004009540A8 Methods and kits for transferases |
| 09/01/2005 | WO2004008099A3 METHODS FOR IDENTIFYING TUMORS THAT ARE RESPONSIVE TO TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 09/01/2005 | WO2003091700A3 Epitope mapping using nuclear magnetic resonance |
| 09/01/2005 | WO2003091417A3 Self-similar ordered microstructural arrays of amphiphilic molecules |
| 09/01/2005 | WO2003089651A3 Assay for quantitating secreted antibodies in lymphocytes supernatant |
| 09/01/2005 | WO2002083873A3 Enzymes |
| 09/01/2005 | US20050193434 IL-21 as a regulator of immunoglobin production |
| 09/01/2005 | US20050192775 Biometric quality control process |
| 09/01/2005 | US20050192770 Biometric quality control process |
| 09/01/2005 | US20050192762 Method and apparatus for chemical genetic programming |
| 09/01/2005 | US20050192760 System and method for plant identification |
| 09/01/2005 | US20050192758 Methods for comparing functional sites in proteins |
| 09/01/2005 | US20050192757 Method of constructing teritiary structure of protein composed of plural chains |
| 09/01/2005 | US20050192755 Methods and systems for identification of macromolecules |
| 09/01/2005 | US20050192754 Protein sequence signals and their applications |
| 09/01/2005 | US20050192693 Systems & methods for realtime determination of asphalt content |
| 09/01/2005 | US20050192494 System for determining insulin dose using carbohydrate to insulin ratio and insulin sensitivity factor |
| 09/01/2005 | US20050192492 Blood sugar level measuring apparatus |
| 09/01/2005 | US20050192491 Blood sugar level measuring apparatus |
| 09/01/2005 | US20050192430 For use as fluorescent labels with central nervous system drugs |
| 09/01/2005 | US20050192239 Methods for identifying risk of breast cancer and treatments thereof |
| 09/01/2005 | US20050192224 Modulation platelet adhesion based on the surface-exposed beta-switch loop of platelet glycoprotein IB-alpha |
| 09/01/2005 | US20050191762 Reagents for assays for ligands |
| 09/01/2005 | US20050191761 Analyte sensing via acridine-based boronate biosensors |
| 09/01/2005 | US20050191758 Apparatus for testing product performance of underground and/or concrete pipes |
| 09/01/2005 | US20050191751 Apparatus which utilizes presence of intrinsic tenase-dependent fibrin as tool in diagnosing individuals as hypercoagulable, normal and/or hypocoagulable; blood disorders |
| 09/01/2005 | US20050191722 Streptavidin-binding peptides and uses thereof |
| 09/01/2005 | US20050191719 Using adenosine triphosphatase as tool for detecting modulators of immune response |
| 09/01/2005 | US20050191718 Methods for measuring phosphatase activity |
| 09/01/2005 | US20050191715 Assay method for measurement of net cholesterol flux |
| 09/01/2005 | US20050191714 Proteome interaction mapping |
| 09/01/2005 | US20050191713 Medicinal use of histone deacetylase inhibitor and method of evaluating antitumor effect thereof |
| 09/01/2005 | US20050191712 immunoassay of acidic repeat protein/immunogens; solid phase synthesis; kits for diagnosis of syphilis |
| 09/01/2005 | US20050191711 Cerebral amyloid plaque precursors for use as diagnostic tool in detection of nervous system disorders |